Company · London Liquidation
Reviral Limited
Research and experimental development on biotechnology
Official record Companies House · updated 27th September 2026 · Sources
Network
The large node is Reviral Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.
Who leads it
Previous officers 20
- Naveed Siddiqi 2021-2022 View profile
- Yi Zhou 2020-2022 View profile
- Ronald Martin Hunt 2020-2022 View profile
- Dr Lawrence Blatt 2019-2022 View profile
- Richard Kender 2019-2022 View profile
- Alex Sapir 2019-2022 View profile
- Dr Isaac Andrew Manke 2018-2020 View profile
- Dr Nanna Liebach LÜNeborg 2018-2021 View profile
- Dr Edward Littler 2016-2019 View profile
- Dr Iain David Dukes 2016-2022 View profile
- Chau Q. Khuong 2015-2022 View profile
- Professor Raymond Schinazi 2015-2019 View profile
- Dr Kenneth Leslie Powell 2015-2022 View profile
- Dr Timothy Jinks 2015-2018 View profile
- Raphael Wisniewski 2015-2022 View profile
- Nikos Nassuphis 2014-2015 View profile
- Khattereh Ahmadi 2011-2015 View profile
- George Stuart Cockerill 2011-2018 View profile
- Richard Angell 2011-2013 View profile
- Michael Jones 2011-2015 View profile
Directors and secretaries as filed at Companies House.
Do you help lead this organisation? Set up its network · How it works
About
- What it does
- Research and experimental development on biotechnology
- Incorporated
- 10/01/2011
- Registered office
- London
- Previous names
- RE:Viral Limited (until 08/12/2015)
RE-Viral Limited (until 24/01/2011)
Ownership
Owned by (1) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.
- Pfizer Specialty UK Limited
75-100% shares, 75-100% voting, appoints directors · notified 2022-06-09
Group
- Reviral Limited
is controlled by Pfizer Specialty UK Limited
Evidence
active 75-100% shares, 75-100% voting, appoints directors · notified 2022-06-09 · source: Companies House PSC register
Ultimately controlled by Pfizer Specialty UK Limited.
1 other company in this group
Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.
Board analysis
Board DNA
How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.
2 directors on the board
- Edwin James Pearson Director · appointed 2022
- David Ian Highton Director · appointed 2022
First-time vs portfolio directors
Portfolio (2)
- Edwin James Pearson Director · appointed 2022
- David Ian Highton Director · appointed 2022
Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.
The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.
Sources
Official record from Companies House. Governance Register calculates the connections.
Record details
- Company number
- 07486063
- Status
- Liquidation
- Type
- Private Limited Company
- Accounts next due
- 28/02/2026
- Edition
- Register edition compiled 27th September 2026
- Labels
- Official record from Companies House · Calculated derived by Governance Register.
Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data